Answers are grounded in this paper and cite their sources.
Pulmonary Arterial Hypertension is a rare, deadly and incurable condition for which management guidelines have recently been revised. Important and remarkable changes include a new strategy-oriented treatment algorithm, based on a risk-stratification approach. Combination therapy is recommended as soon as diagnosis is established for all patients, with a parenteral prostacyclin for the most severe cases. The uncommon nature of the disease and the management complexity require that care is delivered by expert specialised centers.
No takes yet. Share an insight, caveat, or question.
Jean-Luc Vachiéry (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: